| Laila N Belly, | |
|
444 Center St, Manchester, CT 06040-3926 | |
| (860) 731-5522 | |
| (860) 731-5536 |
| Full Name | Laila N Belly |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 444 Center St, Manchester, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013792092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laila N Belly, 2 Waterside Xing Ste 401, Windsor, CT 06095-1588 Ph: (860) 697-3351 | Laila N Belly, 444 Center St, Manchester, CT 06040-3926 Ph: (860) 731-5522 |
News Archive
Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of infectious diseases, announced it has successfully filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) to test SQ109 in patients suffering from H. pylori-related duodenal ulcers, and can now begin Phase 2 studies.
The 5th Annual Jean Sindab Triple Negative Breast Cancer Symposium, sponsored by the Winship Cancer Institute at Emory University, provides an intimate learning environment in which the most current advances in triple-negative breast cancers (TNBC) will be explored.
The coronavirus disease (COVID-19) is straining healthcare resources across the globe, prompting countries to impose social distancing measures to reduce the transmission of the virus. The problem is, the virus can spread even if the infected person has no symptoms, making contact tracing and isolation measures more difficult. Now, a new study reveals the rapidity of asymptomatic SARS-CoV-2 transmission that occurred in a Boston homeless shelter.
The Washington Post reports on how this emerging electronic health record system is impacting the marketplace. In other Health IT news, the Twin Cities' market appears to be full of "early adopters" of online care services, according to the Pioneer Press.
Phase I/II clinical trial data support the use of bosutinib as second- or third-line tyrosine kinase inhibitor therapy in Japanese patients with Philadelphia chromosome-positive chronic myeloid leukaemia.
› Verified 7 days ago
Sarah Zwarick, Counselor Medicare: Not Enrolled in Medicare Practice Location: 587 E Middle Tpke, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Ms. Karen Franes Foley-schain, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 245 Redwood Rd, Manchester, CT 06040 Phone: 860-508-0332 | |
Krista Nordmark, Counselor Medicare: Not Enrolled in Medicare Practice Location: 587 E Middle Tpke, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Sylvester Esangbedo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Elsa Reyes, Counselor Medicare: Medicare Enrolled Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Aliya E Jasensky, Counselor Medicare: Not Enrolled in Medicare Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 | |
Lynda Dyer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 |